Gonadotrophin-releasing hormone analogues for endometriosis

In: Cochrane Database of Systematic Reviews · 2021 · vol. 2021(7) · doi:10.1002/14651858.cd014788 · W3182104692
article OA: green CC0 ⤵ 2 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-09

This Cochrane Review protocol outlines the planned assessment of gonadotrophin-releasing hormone analogues' effectiveness and safety for treating endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of gonadotrophin-releasing hormone analogues (GnRHas) in the treatment of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (37)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK